Literature DB >> 30527242

Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults.

Mauricio E Gamez1, Ryan Kraus2, Michael L Hinni3, Eric J Moore4, Daniel J Ma5, Stephen J Ko6, Jean Claude M Rwigema1, Lisa A McGee1, Michele Y Halyard1, Matthew R Buras7, Robert L Foote5, Samir H Patel8.   

Abstract

OBJECTIVES: The natural history of squamous cell carcinoma (SCC) of the oral cavity (OC) in young adults is unknown. We sought to provide an updated report on treatment outcomes of patients with OC SCC who were 40 years or younger.
MATERIALS AND METHODS: We performed a retrospective analysis of 124 consecutive patients with primary OC SCC treated at Mayo Clinic (1980-2014). Patient and tumor characteristics and treatment approach were abstracted from patient charts.
RESULTS: Median patient age was 35 years (range, 19-40 years). The most common primary site was oral tongue (107 patients; 86.3%). Most patients (101; 81.5%) underwent wide local excision. Surgery alone was curative in 77 patients (62.1%); 47 (37.9%) received radiotherapy, and 26 (21%) received chemotherapy. Five-year overall survival (OS) was 78.1%; 10-year OS was 76.9%. Five-year disease-free survival (DFS) was 66.6%; 5-year local control was 87.6%; and 5-year locoregional control was 78.5%. On multivariable analysis, factors associated with worse OS and DFS were higher pathologic T stage (P = .008), lymph node positivity (P < .001), and disease recurrence (P < .001).
CONCLUSION: Young adults with primary OC SCC may be treated with a similar treatment approach as older adults.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Head and neck cancer; Oral cavity; Oral tongue

Mesh:

Year:  2018        PMID: 30527242     DOI: 10.1016/j.oraloncology.2018.10.014

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  11 in total

1.  Not So Fast: Deintensification Therapy for Locally Advanced Oral Cavity Cancer.

Authors:  Darrion L Mitchell; Steven K Clinton; Matthew O Old
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-01       Impact factor: 7.038

2.  Oral tongue squamous cell carcinomas in young patients according to their smoking status: a GETTEC study.

Authors:  Sophie Deneuve; Joanne Guerlain; Agnès Dupret-Bories; Claire Majoufre; Pierre Philouze; Philippe Ceruse; Marion Perreard; Nicolas Sigaud; Béatrix Barry; Pierre Ransy; Philippe Schultz; Olivier Malard; Sylvain Morinière; Anne Chatellier; Erwan De Monès; Mireille Folia; François Virard; Béatrice Fervers
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-20       Impact factor: 2.503

3.  C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3/9 via the CD64/AKT/mTOR pathway.

Authors:  Shenglin Wang; Qinchao Chen; Xiaodong Yan; Meng Cao; Zhigang Wang
Journal:  Hum Cell       Date:  2021-05-21       Impact factor: 4.174

4.  Older age is a risk factor associated with poor prognosis of patients with squamous cell carcinoma of the oral cavity.

Authors:  Shuwei Chen; Zhu Lin; Jingtao Chen; Ankui Yang; Quan Zhang; Chuanbo Xie; Xing Zhang; Zhongyuan Yang; Wenkuan Chen; Ming Song
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-22       Impact factor: 2.503

Review 5.  A systematic review and meta-analysis of the prognostic role of age in oral tongue cancer.

Authors:  Marta Tagliabue; Pietro Belloni; Rita De Berardinis; Sara Gandini; Francesco Chu; Stefano Zorzi; Caterina Fumagalli; Luigi Santoro; Susanna Chiocca; Mohssen Ansarin
Journal:  Cancer Med       Date:  2021-03-24       Impact factor: 4.452

6.  Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age.

Authors:  Mohssen Ansarin; Rita De Berardinis; Federica Corso; Gioacchino Giugliano; Roberto Bruschini; Luigi De Benedetto; Stefano Zorzi; Fausto Maffini; Fabio Sovardi; Carolina Pigni; Donatella Scaglione; Daniela Alterio; Maria Cossu Rocca; Susanna Chiocca; Sara Gandini; Marta Tagliabue
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

7.  Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell Carcinoma.

Authors:  Wadad S Mneimneh; Bin Xu; Charles Ghossein; Bayan Alzumaili; Shenon Sethi; Ian Ganly; Anjanie Khimraj; Snjezana Dogan; Nora Katabi
Journal:  Head Neck Pathol       Date:  2021-04-02

8.  Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.

Authors:  Giovanni Pentangelo; Steven Paul Nisticò; Eugenio Provenzano; Giusy Ylenia Cisale; Luigi Bennardo
Journal:  Medicina (Kaunas)       Date:  2021-06-02       Impact factor: 2.430

9.  TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma.

Authors:  Ke Zhang; Hong Zhou; Bo Yan; Xuanping Cao
Journal:  Cancer Cell Int       Date:  2020-05-06       Impact factor: 5.722

10.  Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.

Authors:  Kyriakos Chatzopoulos; Sotiris Sotiriou; Andrea R Collins; Panagiotis Kartsidis; Alessandra C Schmitt; Xianfeng Chen; Khashayarsha Khazaie; Michael L Hinni; Colleen A Ramsower; Matthew A Zarka; Samir H Patel; Joaquin J Garcia
Journal:  Head Neck Pathol       Date:  2020-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.